Your browser is no longer supported. Please, upgrade your browser.
Settings
BCR C. R. Bard, Inc. daily Stock Chart
BCR [NYSE]
C. R. Bard, Inc.
IndexS&P 500 P/E28.16 EPS (ttm)7.50 Insider Own0.20% Shs Outstand74.10M Perf Week0.30%
Market Cap15.65B Forward P/E18.61 EPS next Y11.35 Insider Trans-60.73% Shs Float73.27M Perf Month-4.28%
Income504.40M PEG2.45 EPS next Q2.73 Inst Own89.00% Short Float1.71% Perf Quarter-3.36%
Sales3.62B P/S4.33 EPS this Y-52.90% Inst Trans-1.53% Short Ratio2.45 Perf Half Y-6.56%
Book/sh23.24 P/B9.09 EPS next Y10.57% ROA9.80% Target Price242.86 Perf Year12.97%
Cash/sh13.45 P/C15.70 EPS next 5Y11.50% ROE32.20% 52W Range171.39 - 238.88 Perf YTD12.01%
Dividend1.04 P/FCF52.35 EPS past 5Y-19.80% ROI6.40% 52W High-11.60% Beta0.65
Dividend %0.49% Quick Ratio2.10 Sales past 5Y4.70% Gross Margin62.90% 52W Low23.22% ATR4.72
Employees14900 Current Ratio2.60 Sales Q/Q8.80% Oper. Margin18.40% RSI (14)46.08 Volatility2.08% 2.38%
OptionableYes Debt/Eq0.95 EPS Q/Q209.80% Profit Margin13.90% Rel Volume0.92 Prev Close208.74
ShortableYes LT Debt/Eq0.95 EarningsOct 25 AMC Payout14.40% Avg Volume511.65K Price211.18
Recom2.60 SMA20-0.79% SMA50-2.67% SMA200-2.41% Volume471,974 Change1.17%
Sep-16-16Upgrade Wells Fargo Market Perform → Outperform
Jul-27-16Reiterated Deutsche Bank Hold $234 → $240
Jul-27-16Reiterated Barclays Equal Weight $224 → $235
Jul-08-16Downgrade BofA/Merrill Buy → Neutral
May-24-16Reiterated Barclays Equal Weight $212 → $224
Apr-28-16Reiterated Barclays Equal Weight $195 → $212
Mar-17-16Initiated Nomura Neutral
Nov-12-15Initiated Citigroup Buy
Aug-27-15Upgrade Goldman Neutral → Buy
Apr-24-15Reiterated Barclays Equal Weight $175 → $185
Jan-30-15Reiterated Barclays Equal Weight $150 → $175
Jun-18-14Downgrade Barclays Overweight → Equal Weight $155 → $150
Mar-06-14Reiterated Barclays Overweight $150 → $160
Jan-09-14Reiterated Barclays Overweight $140 → $150
Oct-23-13Reiterated Barclays Overweight $135 → $140
Sep-04-13Initiated Needham Hold
Jul-24-13Reiterated Barclays Overweight $112 → $125
Jun-04-13Reiterated Deutsche Bank Hold $98 → $106
Mar-08-13Reiterated Northland Capital Market Perform $105 → $111
Feb-01-13Reiterated Barclays Overweight $117 → $112
Dec-01-16 10:05AM  Baxter Makes Significant Advancements in Hemodialysis Treatments
Nov-30-16 10:30AM  Bard to Present at the Citi Healthcare Conference Business Wire
Nov-23-16 10:30AM  Bard to Present at the Piper Jaffray Healthcare Conference Business Wire
Nov-22-16 02:17PM  BARD C R INC /NJ/ Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance
Nov-17-16 08:11AM  CR Bard (BCR) Sees Hammer Chart Pattern: Time to Buy?
Nov-09-16 07:28AM  C.R. Bard, Inc. (New Jersey) breached its 50 day moving average in a Bullish Manner : BCR-US : November 9, 2016
Nov-08-16 10:30AM  Bard to Present at the Stifel Healthcare Conference Business Wire
Nov-02-16 06:02PM  DENTSPLY (XRAY) Q3 Earnings: Is Disappointment in Store?
08:05AM  Particle Therapy Business Witnessed Continued Growth Momentum in 4Q16
Nov-01-16 04:41PM  Dividend Aristocrats in Focus Part 25: CR Bard
01:04PM  BARD C R INC /NJ/ Financials
Oct-28-16 02:50PM  ETFs with exposure to C.R. Bard, Inc. (New Jersey) : October 28, 2016
Oct-26-16 01:12PM  BARD C R INC /NJ/ Files SEC form 10-Q, Quarterly Report
11:45AM  C.R. Bard, Inc. (New Jersey) : BCR-US: Dividend Analysis : October 24th, 2016 (record date) : By the numbers : October 26, 2016
10:21AM  C.R. Bard (BCR) Beats Q3 Earnings & Sales, FY16 View Up
09:42AM  C.R. Bard, Inc. (New Jersey) :BCR-US: Earnings Analysis: Q3, 2016 By the Numbers : October 26, 2016
04:05AM  Edited Transcript of BCR earnings conference call or presentation 25-Oct-16 9:00pm GMT
Oct-25-16 05:00PM  C R Bard Inc Earnings Call scheduled for 5:00 pm ET today
04:33PM  BARD C R INC /NJ/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
04:32PM  C.R. Bard beats Street 3Q forecasts
04:15PM  Bard Announces Third Quarter Results Business Wire
07:07AM  Q3 2016 C R Bard Inc Earnings Release - After Market Close
Oct-24-16 04:19PM  C.R. Bard (BCR) to Report Q3 Earnings: What's in the Cards?
08:30AM  5 Stocks That Could Make Huge Earnings Moves This Week at Insider Monkey
Oct-21-16 09:01AM  BARD C R INC /NJ/ Files SEC form 8-K, Change in Directors or Principal Officers
Oct-19-16 08:22AM  C.R. Bard, Inc. (New Jersey) breached its 50 day moving average in a Bullish Manner : BCR-US : October 19, 2016
Oct-14-16 12:16PM  Private equity firms line up bids for BSN Medical - sources Reuters
11:29AM  German bandage BSN Medical seen attracting bids from peers, private equity - sources Reuters
10:22AM  ETFs with exposure to C.R. Bard, Inc. (New Jersey) : October 14, 2016
Oct-12-16 04:15PM  Bard Declares Quarterly Dividend Business Wire
Oct-05-16 08:32AM  C.R. Bard, Inc. (New Jersey) breached its 50 day moving average in a Bearish Manner : BCR-US : October 5, 2016
Oct-03-16 10:30AM  Bard to Host Earnings Conference Call on October 25, 2016 Business Wire
Oct-01-16 01:17PM  Timothy Ring, CEO and Chairman of C.R. Bard Inc., Sold 92,293 Shares of the Company on Sept. 28
Sep-29-16 08:15PM  C.r. Bard Inc (BCR) Chairman and CEO Timothy M Ring Sold $21 million of Shares
Sep-27-16 08:15PM  C.r. Bard Inc (BCR) Chairman and CEO Timothy M Ring Sold $25.2 million of Shares
Sep-22-16 08:30AM  LUTONIX® Global Real-World Registry 24-Month Outcomes Presented at VIVA 2016 Business Wire
Sep-20-16 11:36AM  C.R. Bard, Inc. (New Jersey) Value Analysis (NYSE:BCR) : September 20, 2016
08:49AM  CR Bard (BCR) Gets FDA's IDE Approval for Lutonix DCB
Sep-19-16 05:37PM  FDA Approves 6-Month Primary End Point for the Lutonix® Below-the-Knee Drug Coated Balloon Business Wire
08:13AM  C.R. Bard, Inc. (New Jersey) breached its 50 day moving average in a Bullish Manner : BCR-US : September 19, 2016
Sep-16-16 06:46AM  C.R. Bard upgraded by Wells Fargo
Sep-09-16 10:26AM  ETFs with exposure to C.R. Bard, Inc. (New Jersey) : September 9, 2016
Sep-06-16 11:00AM  Bard to Present at Morgan Stanley Global Healthcare Conference Business Wire
Sep-01-16 08:04AM  A Look at How C.R. Bards Valuation Compares to Its Peers
Aug-31-16 04:04PM  Analyzing C.R. Bards Strong Product Pipeline
03:04PM  C.R. Bard Is Expected to Have a Strong Performance in 2016
12:34PM  Analysts Recommendations for C.R. Bard in 2016
Aug-29-16 11:04AM  ETFs with exposure to C.R. Bard, Inc. (New Jersey) : August 29, 2016
Aug-18-16 06:11PM  ETFs with exposure to C.R. Bard, Inc. (New Jersey) : August 18, 2016
Aug-04-16 02:41PM  ETFs with exposure to C.R. Bard, Inc. (New Jersey) : August 4, 2016
Aug-03-16 01:17PM  C.R. Bard, Inc. (New Jersey) :BCR-US: Earnings Analysis: Q2, 2016 By the Numbers : August 3, 2016
Aug-02-16 04:59PM  Cardinal Health (CAH) Tops Q4 Earnings, '17 View Impressive
11:04AM  Analysts Recommendations for C.R. Bard after Its 2Q Earnings Post
09:05AM  Analyzing the Near-Term Product Pipeline of C.R. Bard
Aug-01-16 11:06AM  C.R. Bards New Treatments for Hernia Are Key Growth Drivers
09:08AM  C.R. Bards Buying Spree for Its Urology Segment Is Paying Off
Jul-29-16 11:17AM  C.R. Bards Vascular Segment Flowing Well despite Tougher Comps
11:17AM  C.R. Bard Registered Strong 2Q16 Performance, Beat Estimates
06:38AM  Did Baxter International Beat 2Q16 Earnings Estimates?
Jul-27-16 03:19PM  C.R. Bard (BCR) Beats Q2 Earnings & Sales, FY16 View Up
10:46AM  BARD C R INC /NJ/ Files SEC form 10-Q, Quarterly Report
01:26AM  Edited Transcript of BCR earnings conference call or presentation 26-Jul-16 9:00pm GMT
Jul-26-16 05:00PM  C R Bard Inc Earnings Call scheduled for 5:00 pm ET today
04:37PM  C.R. Bard tops Street 2Q forecasts
04:24PM  BARD C R INC /NJ/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
04:15PM  Bard Announces Second Quarter Results Business Wire
07:07AM  Q2 2016 C R Bard Inc Earnings Release - After Market Close
Jul-22-16 05:22PM  Johnson & Johnson Reports 4% Sales Growth for the Second Quarter
Jul-21-16 06:34PM  C.R. Bard (BCR) Well Poised to Beat Q2 Earnings Estimates?
08:30AM  Should You Buy CR Bard (BCR) Ahead of Earnings?
Jul-19-16 06:24PM  The Yacktman Focused Fund Sells Out of C.R. Bard Inc.
Jul-18-16 07:01PM  Cramer: These Stocks Are the Key to the Bull Market
Jul-12-16 05:08PM  How Does Varian Medical Systems Valuation Compare to Peers?
Jul-11-16 08:09AM  The Cooper Companies (COO) Scales a New 52-Week High
05:05AM  5 Stocks Hit 52-Week High Prices
Jul-05-16 09:29AM  CR Bard: Expansion Plans on Track, Product Pipeline Strong
Jul-01-16 11:00AM  Bard to Host Earnings Conference Call on July 26, 2016 Business Wire
Jun-30-16 03:23PM  How Varian Is Addressing Existing Gaps in Cancer Treatment
10:30AM  How Varians Imaging Components Segment Hopes to Drive Growth
08:27AM  CR Bard (BCR) at 52-Week High on Strong Product Pipeline
Jun-28-16 09:41AM  DENTSPLY Sirona Set to Acquire MIS Implants for $375M
Jun-27-16 04:11AM  How Did Varians Imaging Components Business Perform?
12:41AM  What Are the Terms of Varians Imaging Components Spin-Off?
Jun-22-16 10:02AM  The 3 Worst Dividend Aristocrats for Income-Hungry Investors at Motley Fool
Jun-21-16 12:54PM  5 Companies Have Hit 5a-Week Highs
12:48PM  ETFs with exposure to C.R. Bard, Inc. (New Jersey) : June 21, 2016
07:00AM  LabCorp Sees Balanced Growth; Covance Synergy on Track
Jun-14-16 01:14PM  'Dividend Aristocrats' may get messy and overvalued, warns portfolio manager
Jun-13-16 02:59PM  Jim Cramer -- 'The Real Market's Healthier,' So Ignore the Bears
07:07AM  Becton, Dickinson (BDX) Inks Partnership Deal with CAPS
Jun-09-16 11:16AM  18 boring companies whose stocks are quietly hitting all-time highs at MarketWatch
Jun-08-16 04:15PM  Bard Increases Quarterly Dividend Business Wire
04:15PM  Bard Announces $500 Million Share Repurchase Authorization Business Wire
Jun-07-16 12:30PM  5 Companies Achieve 5a-Week Highs
Jun-06-16 02:40PM  C.R. Baird Reverses Bullish Trajectory, Should Continue to Rally
May-24-16 11:17AM  Billionaire Paul Tudor Jones Trims His Funds Fee Structure Amid Underperformance, Bets On These Stocks Heading Into Q2 at Insider Monkey
May-23-16 09:08AM  IHIs Large Caps on May 19: Baxter Offer on Baxalta Exchange Was Oversubscribed
May-12-16 01:05AM  AMIA APD Momentum Drives Baxters Renal Business Growth in 1Q16 Market Realist
May-09-16 05:42PM  BARD C R INC /NJ/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
May-06-16 08:46AM  6 Cash-Rich Stocks With Bullish Stock Charts at TheStreet
C. R. Bard, Inc., together with its subsidiaries, designs, manufactures, packages, distributes, and sells medical, surgical, diagnostic, and patient care devices worldwide. The company offers vascular products, such as percutaneous transluminal angioplasty catheters, chronic total occlusion catheters, guidewires, fabrics, meshes, introducers, and accessories; valvuloplasty balloons; peripheral vascular stents, self-expanding and balloon-expandable covered stents, and vascular grafts; vena cava filters; biopsy devices; and temporary pacing electrode catheters for the treatment of peripheral vascular and end-stage renal diseases, and heart arrhythmias. It also provides urology products, including Foley catheters to reduce the rate of urinary tract infections; fecal incontinence products; brachytherapy devices and radioactive seeds for the treatment of prostate cancer; intermittent urinary drainage catheters, and urine monitoring and collection systems; ureteral stents; specialty devices for stone removal procedures; surgical slings and pelvic floor repair products; catheter stabilization devices; and products for therapeutic hypothermia. In addition, the company offers oncology products, such as specialty vascular access catheters and ports, vascular access ultrasound devices, dialysis access catheters, and enteral feeding devices to treat and manage various cancers, and other diseases and disorders. Further, it provides surgical specialty products comprising implanted grafts and fixation devices for hernia and soft tissue repairs; and hemostats and surgical sealants, as well as irrigation, wound drainage, and original equipment manufacturers' products. The company sells its products directly to hospitals, individual healthcare professionals, extended care facilities, and alternate site facilities through hospital/surgical supply and other medical specialty distributors. C. R. Bard, Inc. was founded in 1907 and is headquartered in Murray Hill, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HOLLAND CHRISTOPHER SSenior Vice President and CFOOct 28Option Exercise95.993,971381,17629,689Oct 31 04:34 PM
HOLLAND CHRISTOPHER SSenior Vice President and CFOOct 28Sale211.125,7241,208,43323,965Oct 31 04:34 PM
RING TIMOTHY MChairman and CEOSep 28Option Exercise84.5837,2933,154,055133,323Sep 29 04:14 PM
RING TIMOTHY MChairman and CEOSep 28Sale227.3437,2938,478,14096,030Sep 29 04:14 PM
RING TIMOTHY MChairman and CEOSep 27Option Exercise84.7255,0004,659,717151,030Sep 29 04:14 PM
RING TIMOTHY MChairman and CEOSep 27Sale228.1355,00012,547,09996,030Sep 29 04:14 PM
RING TIMOTHY MChairman and CEOSep 26Option Exercise86.1555,0004,737,975151,030Sep 27 04:05 PM
RING TIMOTHY MChairman and CEOSep 26Sale227.9955,00012,539,47096,030Sep 27 04:05 PM
RING TIMOTHY MChairman and CEOSep 23Option Exercise86.1555,0004,737,975151,030Sep 27 04:05 PM
RING TIMOTHY MChairman and CEOSep 23Sale229.9255,00012,645,62496,030Sep 27 04:05 PM
Larson Betty DVP - Human ResourcesSep 19Option Exercise149.064,032601,01010,298Sep 20 03:24 PM
Larson Betty DVP - Human ResourcesSep 19Sale225.334,032908,5246,266Sep 20 03:24 PM
Khichi Samrat S.Sr. VP, Gen Counsel & Secy.Sep 06Option Exercise145.839,1831,339,15722,023Sep 08 09:43 AM
DeFord John ASr. VP Sci Tech and Clin AfrsSep 06Option Exercise151.817,9281,203,55029,535Sep 08 09:43 AM
Khichi Samrat S.Sr. VP, Gen Counsel & Secy.Sep 06Sale221.019,1832,029,52012,840Sep 08 09:43 AM
DeFord John ASr. VP Sci Tech and Clin AfrsSep 06Sale221.067,9281,752,58421,607Sep 08 09:43 AM
HOLLAND CHRISTOPHER SSenior Vice President and CFOMay 27Option Exercise95.993,970381,08031,306Jun 01 12:51 PM
HOLLAND CHRISTOPHER SSenior Vice President and CFOMay 27Sale219.893,970872,94527,336Jun 01 12:51 PM
Groetelaars John PGroup PresidentMay 17Sale219.881,162255,50517,431May 18 02:56 PM
Thompson Tommy GDirectorMay 12Option Exercise83.4750041,7377,036May 16 09:57 AM
Thompson Tommy GDirectorMay 12Sale219.52500109,7606,536May 16 09:57 AM
WHITE TONY LDirectorMay 05Option Exercise73.991,20088,78814,671May 09 11:50 AM
WHITE TONY LDirectorMay 05Sale216.191,200259,42313,471May 09 11:50 AM
Beasley Jim CGroup PresidentApr 28Option Exercise168.874,709795,18527,378May 02 09:46 AM
Beasley Jim CGroup PresidentApr 28Sale215.004,7091,012,43522,669May 02 09:46 AM
Luboff Sharon MGroup Vice PresidentApr 27Option Exercise86.1510,000861,45033,706Apr 29 10:14 AM
Luboff Sharon MGroup Vice PresidentApr 27Sale210.0010,0002,100,00023,706Apr 29 10:14 AM
Lupisella Frank JrVice President and ControllerFeb 23Sale190.252,300437,57514,495Feb 24 04:50 PM
Christian Patricia GVP -Quality, Reg & Med AffairsFeb 22Sale190.003,182604,5809,240Feb 24 04:50 PM
Luboff Sharon MGroup Vice PresidentFeb 22Sale190.0013,3212,530,99023,706Feb 24 04:50 PM
Collins Timothy PGroup PresidentFeb 17Sale187.48974182,60629,276Feb 18 05:06 PM
DeFord John ASr. VP Sci Tech and Clin AfrsFeb 17Sale187.44661123,89821,607Feb 18 05:06 PM
RING TIMOTHY MChairman and CEOFeb 17Sale187.622,453460,22697,370Feb 18 05:06 PM
WEILAND JOHN HPresident and COOFeb 17Sale187.451,618303,30161,590Feb 18 05:06 PM
WELTERS ANTHONYDirectorFeb 16Option Exercise73.991,20088,7883,692Feb 18 05:06 PM
WELTERS ANTHONYDirectorFeb 16Sale187.471,784334,4531,908Feb 18 05:06 PM
Collins Timothy PGroup PresidentFeb 12Sale182.80618112,97131,435Feb 16 05:36 PM
RING TIMOTHY MChairman and CEOFeb 12Sale182.241,915348,992102,200Feb 16 05:36 PM
RING TIMOTHY MChairman and CEOFeb 11Sale182.8122,0884,037,863104,115Feb 16 05:36 PM
Collins Timothy PGroup PresidentFeb 11Sale182.247,2751,325,79932,053Feb 16 05:36 PM
Groetelaars John PGroup PresidentFeb 10Sale187.163,319621,18318,841Feb 12 02:08 PM
WEILAND JOHN HPresident and COOFeb 09Sale181.108,8981,611,44653,078Feb 10 05:45 PM
Collins Timothy PGroup PresidentFeb 09Sale181.244,205762,09625,076Feb 10 05:45 PM
DeFord John ASr. VP Sci Tech and Clin AfrsFeb 09Sale180.623,407615,35818,710Feb 10 05:45 PM
RING TIMOTHY MChairman and CEOFeb 09Sale181.204,836876,29493,896Feb 10 05:45 PM
Naughton Gail KDirectorFeb 02Sale187.88584109,7251,511Feb 03 10:26 AM
Thompson Tommy GDirectorFeb 02Sale188.752,319437,7176,536Feb 03 10:26 AM
BARD C R INC /NJ/10% OwnerJan 21Buy0.011,000100Jan 21 05:24 PM
DeFord John ASr. VP Sci Tech and Clin AfrsDec 16Option Exercise97.694,662455,40728,308Dec 17 05:27 PM
Christian Patricia GVP -Quality, Reg & Med AffairsDec 16Sale190.001,908362,5209,413Dec 17 05:27 PM
DeFord John ASr. VP Sci Tech and Clin AfrsDec 16Sale190.004,662885,78023,646Dec 17 05:27 PM
WEILAND JOHN HPresident and COODec 16Sale190.306,0961,160,09367,409Dec 17 05:27 PM
WEILAND JOHN HPresident and COODec 15Option Exercise84.5813,5901,149,37487,095Dec 17 05:27 PM
WEILAND JOHN HPresident and COODec 15Sale187.6713,5902,550,44373,505Dec 17 05:27 PM
RING TIMOTHY MChairman and CEODec 15Sale187.679,1431,715,828101,694Dec 17 05:27 PM
DeFord John ASr. VP Sci Tech and Clin AfrsDec 14Option Exercise84.585,627475,90429,273Dec 16 12:37 PM
Beasley Jim CGroup PresidentDec 14Option Exercise103.3420,5772,126,52844,890Dec 16 12:37 PM
WEILAND JOHN HPresident and COODec 14Option Exercise97.6933,5693,279,188112,978Dec 16 12:37 PM
WEILAND JOHN HPresident and COODec 14Sale184.2533,5696,185,03073,505Dec 16 12:37 PM
Beasley Jim CGroup PresidentDec 14Sale184.7820,5773,802,14924,313Dec 16 12:37 PM
DeFord John ASr. VP Sci Tech and Clin AfrsDec 14Sale184.005,6271,035,36823,646Dec 16 12:37 PM